Blog

Informes especiales

Asistencia para el copago de infusiones: Cómo acceder a ayuda financiera para terapias con inmunoglobulina intravenosa (IVIG) y terapias biológicas.

Mother and daughter reviewing documents in order to apply for copay assistance

Discovering you need expensive infusion therapy for conditions like CIDP, myasthenia gravis, or Crohn’s disease is overwhelming enough. Then comes the financial shock: copays ranging from hundreds to thousands of dollars per treatment. If you’re facing high out-of-pocket costs for IVIG or biologic infusions, manufacturer copay assistance programs can dramatically reduce or eliminate what you pay.

AmeriPharma Infusion Centers has secured over $55 million in financial assistance for patients requiring infusion therapy. Our dedicated Copay Assistance Specialists connect patients with manufacturer programs, foundation grants, and patient assistance resources (often reducing costs to $0 out-of-pocket).

En este artículo descubrirás:

  • How manufacturer copay assistance programs work alongside insurance 
  • Who qualifies for IVIG copay help and financial assistance 
  • Which IVIG and biologic therapies commonly have copay programs available 
  • AmeriPharma’s 3-step process for securing financial support 
  • Answers to common questions about insurance coverage and copay assistance

How Infusion Copay Assistance Works

Infusion copay assistance refers to financial support programs that help patients afford out-of-pocket costs for specialty medications administered through IV or injection. These programs work alongside your health insurance (not as a replacement) to cover copays, coinsurance, and deductibles.

When infusion medications cost $10,000 to $30,000 per dose, even a 20% coinsurance translates to $2,000 to $6,000 per treatment. Manufacturer copay assistance programs and independent charitable foundations step in to cover these patient responsibility amounts.

The Three Types of Financial Assistance

Multiple funding sources exist to help patients afford IVIG copay help and biologic infusion costs. Understanding which programs you qualify for is the first step toward reducing your out-of-pocket expenses.

Program TypeWho QualifiesWhat It CoversExamples
Manufacturer Copay AssistancePatients with commercial/private insuranceCopays, coinsurance, deductibles for specific brand medicationsPrivigen Connect, CSL Behring programs, Takeda Patient Support
Independent Charitable FoundationsPatients meeting income/diagnosis criteria (often 500% of federal poverty level)Out-of-pocket costs for qualifying conditionsPatient Access Network Foundation, HealthWell Foundation, Infusion Access Foundation
Patient Assistance Programs (PAPs)Uninsured or underinsured patients with limited incomeFree or drastically reduced medication costsManufacturer-specific programs (varies by drug)

Who Qualifies for Infusion Copay Assistance?

Most patients with diagnosed conditions requiring infusion therapy qualify for at least one form of financial assistance. Eligibility depends on your insurance type, income level (for some programs), and whether your prescribed medication has manufacturer support available.

Manufacturer copay assistance typically requires commercial or private insurance, though many programs have no income restrictions. Independent charitable foundations serve both insured and uninsured patients who meet income criteria (usually up to 500% of federal poverty level). Patient assistance programs focus on uninsured or underinsured individuals with limited income. The table below shows which common IVIG and biologic medications have copay programs available.

IVIG and Biologic Medications With Copay Assistance

Manufacturer copay assistance is widely available for infusion therapies AmeriPharma provides:

MedicamentoUsed ForCopay Programs Available
Privigen (IVIG)Primary immunodeficiency, CIDP, chronic ITPPrivigen Connect copay support
Gammagard (IVIG)Primary immunodeficiency, CIDP, multifocal motor neuropathyTakeda patient support programs
Bivigam (IVIG)Primary immunodeficiencyADMA Biologics financial assistance
Remicade (Biologic)Crohn’s disease, rheumatoid arthritis, ulcerative colitisJohnson and Johnson patient support
Stelara (Biologic)Crohn’s disease, ulcerative colitis, psoriatic arthritis , and Plaque psoriasis Janssen CarePath savings program

If your medication isn’t listed, contact AmeriPharma’s Copay Assistance Specialists at (714) 551-6629. We’ll research your specific medication and connect you with available programs [2,3].

Over $55 Million Secured for Patients

AmeriPharma Infusion Centers’ financial assistance expertise has resulted in life-changing savings for thousands of patients:

  • Over $55 million secured in financial assistance for IVIG and biologic therapy patients
  • 30% de nuestros pacientes pagan $0 de su propio bolsillo. for their infusion therapy
  • Average copay assistance ranges from $8,000 to $15,000 annually per patient
  • Patients who were considering stopping treatment due to costs are now able to continue
  • Families facing financial hardship have found relief through coordinated assistance programs

As an example, a patient prescribed Privigen for CIDP facing a $4,200 quarterly copay could potentially reduce that to $0 through combined manufacturer and foundation assistance. Families considering stopping treatment due to costs often find relief through coordinated support programs.

AmeriPharma’s 3-Step Copay Assistance Process

AmeriPharma Infusion Centers has developed an in-house process to connect patients with every available dollar of financial assistance. Our Especialistas en asistencia para copagos handle the paperwork, applications, and follow-ups so you can focus on your health.

Step 1: Automated Screening and Program Matching

The moment you’re referred to AmeriPharma, our advanced software automatically searches for all available copay assistance programs matching your situation. The system evaluates your prescribed medication (specific IVIG brand or biologic), insurance type, diagnosis codes, and manufacturer program availability. Our software identifies foundation programs offering the greatest patient financial assistance; not just the obvious programs, but every potential funding source.

Step 2: Expert Application Support

A dedicated Copay Assistance Specialist is assigned to your case. Your specialist will explain each program’s requirements in plain language, complete applications on your behalf (with your authorization), and gather necessary documentation from your physician. They submit all paperwork correctly the first time and follow up proactively with program administrators to prevent delays.

Copay assistance applications require specific medical documentation and precise coordination between you, your doctor, and program administrators. AmeriPharma’s team handles this daily, understanding exactly what each program requires to approve funding quickly.

Step 3: Ongoing Status Updates and Re-Enrollment

Throughout the process, you receive automatic status alerts, transparent communication about approval timelines, and proactive troubleshooting if additional information is needed. Most programs require annual re-enrollment; our team coordinates this proactively. If your insurance or medication changes, we adjust strategies to maintain your coverage.

Frequently Asked Questions About Infusion Copay Assistance

Does insurance cover IVIG infusion therapy?

Yes, when medically necessary. Insurance covers IVIG prescribed by a physician for diagnosed conditions such as primary immunodeficiency, CIDP, or myasthenia gravis. However, coverage typically includes patient cost-sharing through copays, coinsurance, or deductibles (sometimes hundreds to thousands per treatment). Copay assistance programs help cover these out-of-pocket costs.

Can I use Privigen copay assistance if I have Medicare?

Manufacturer programs like Privigen Connect are generally available only to patients with commercial insurance; federal regulations prohibit manufacturers from directly subsidizing Medicare copays. However, Medicare patients can access independent charitable foundations that provide financial assistance for qualifying diagnoses and income levels. Our specialists help identify all available options for Medicare patients [1,2].

How long does it take to get approved for copay assistance?

Most patients are approved for manufacturer copay assistance within 7 to 14 days of application submission. Independent charitable foundation approvals may take longer depending on fund availability, but our team follows up proactively to prevent delays.

Get Started With Infusion Copay Assistance Today

If you’ve been prescribed IVIG therapy, biologics, or other specialty infusions, you don’t have to face high out-of-pocket costs alone. AmeriPharma’s Copay Assistance Specialists are ready to connect you with every available dollar of financial support.

Next steps:

Don’t let high copays prevent you from receiving the infusion therapy you need. Contacto AmeriPharma today and discover how much you can save.

REFERENCIAS:

  1. Specialty Pharmacy Continuum. (2026). Immunoglobulin Financial Support for Ig Patients. https://www.specialtypharmacycontinuum.com/Policy/Article/02-26/Immunoglobulin-Financial-Support-for-Ig-Patients/79759
  2. CSL Behring. Privigen Patient Support. https://www.privigen.com/patient-resources/pi
  3. BIVIGAM. Support and Resources. https://www.bivigam.com/support-resources
Esta información no sustituye el consejo ni el tratamiento médico. Consulte a su médico o profesional de la salud sobre su afección médica antes de comenzar cualquier tratamiento nuevo. AmeriPharma® Infusion Center no asume ninguna responsabilidad por la información proporcionada ni por ningún diagnóstico o tratamiento realizado como resultado, ni se responsabiliza de la fiabilidad del contenido. AmeriPharma® Infusion Center no opera todos los sitios web/organizaciones aquí mencionados, ni se responsabiliza de la disponibilidad o fiabilidad de su contenido. Estos listados no implican ni constituyen un respaldo, patrocinio ni recomendación por parte de AmeriPharma® Infusion Center. Esta página web puede contener referencias a medicamentos recetados de marca que son marcas comerciales o marcas registradas de fabricantes farmacéuticos no afiliados a AmeriPharma® Infusion Center.
David Mogote
REVISADO MÉDICAMENTE POR David Mogote

David Mogote es actualmente Director de Gestión del Ciclo de Ingresos en AmeriPharma. Nació y creció en Norwalk, California, y se graduó de Cypress College en 2002. La parte más gratificante de su trabajo es ayudar a los pacientes a comprender sus beneficios de atención médica y buscar la mejor solución para ayudarles con sus elevados gastos de bolsillo. Mogote ha visto crecer la industria de la infusión domiciliaria desde dentro y ha sido testigo de los numerosos cambios en los sistemas de salud comerciales, gubernamentales y privados, lo que le ha permitido acumular una vasta experiencia y conocimiento. En su tiempo libre, disfruta de pasar tiempo con su familia en salidas de fin de semana y viajes a la playa.

es_MXSpanish